BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

7.01
Delayed Data
As of Aug 20
 -0.09 / -1.27%
Today’s Change
3.95
Today|||52-Week Range
7.49
+42.77%
Year-to-Date

Today’s Trading

Previous close7.10
Today’s open7.14
Day’s range6.91 - 7.14
Volume402,307
Average volume (3 months)782,497
Market cap$743.2M
Data as of 4:00pm ET, 08/20/2018

Growth & Valuation

Earnings growth (last year)-4.00%
Earnings growth (this year)-15.24%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)-4.43%
P/E ratioNM
Price/Sales16.46
Price/Book8.08

Competitors

 Today’s
change
Today’s
% change
CYADCelyad SA+0.14+0.50%
NSTGNanoString Technolog...+0.54+3.86%
MRSNMersana Therapeutics...+0.73+6.00%
SELBSelecta Biosciences ...-0.34-2.68%
Data as of 4:00pm ET, 08/20/2018

Financials

Next reporting dateNovember 8, 2018
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$25.2M
Annual profit (last year)-$65.8M
Net profit margin-261.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts